Academic Journal
View in EDS

Mismatch repair and microsatellite instability testing for Immune Checkpoint Inhibitor Therapy: ASCO endorsement of College of American Pathologists Guideline

Bibliographic Details
Title: Mismatch repair and microsatellite instability testing for Immune Checkpoint Inhibitor Therapy: ASCO endorsement of College of American Pathologists Guideline
Authors: Vikas, Praveen, Messersmith, Hans, Compton, Carolyn, Sholl, Lynette, Broaddus, Russell R., Davis, Anjee, Estevez-Diz, Maria, Garje, Rohan, Konstantinopoulos, Panagiotis A., Leiser, Aliza, Mills, Anne M., Norquist, Barbara, Overman, Michael J., Sohal, Davendra, Turkington, Richard C., Johnson, Tyler
Source: Vikas, P, Messersmith, H, Compton, C, Sholl, L, Broaddus, R R, Davis, A, Estevez-Diz, M, Garje, R, Konstantinopoulos, P A, Leiser, A, Mills, A M, Norquist, B, Overman, M J, Sohal, D, Turkington, R C & Johnson, T 2023, 'Mismatch repair and microsatellite instability testing for Immune Checkpoint Inhibitor Therapy: ASCO endorsement of College of American Pathologists Guideline', Journal of Clinical Oncology, vol. 41, no. 10, pp. 1943-1948. https://doi.org/10.1200/jco.22.02462
Publication Year: 2023
Collection: Queen's University Belfast: Research Portal
Subject Terms: Cancer Research, Oncology, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being
Description: The College of American Pathologists (CAP) has developed a guideline on testing for mismatch repair (MMR) and microsatellite instability (MSI) for patients considered for immune checkpoint inhibitor therapy. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. The CAP guideline was reviewed for developmental rigor by methodologists. An ASCO Endorsement Panel subsequently reviewed the content and the recommendations. The ASCO Endorsement Panel determined that the recommendations from the CAP guideline, published on August 3, 2022, are clear, thorough, and based on the most relevant scientific evidence. ASCO endorses . Within the guideline, MMR immunohistochemistry (IHC), MSI polymerase chain reaction, and MSI next-generation sequencing are all recommended testing options for colorectal cancer, MMR-IHC and MSI-polymerase chain reaction for gastroesophageal and small bowel cancer, and only MMR-IHC for endometrial cancer. No recommendation in favor of any testing method over another could be made for any other cancer. Tumor mutational burden was not recommended as a surrogate for DNA MMR deficiency. If MMR deficiency consistent with Lynch syndrome is detected, it should be communicated to the treating physician.Additional information is available at www.asco.org/molecular-testing-and-biomarkers-guidelines.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISSN: 0732-183X
1527-7755
Relation: info:eu-repo/semantics/altIdentifier/pissn/0732-183X; info:eu-repo/semantics/altIdentifier/eissn/1527-7755
DOI: 10.1200/jco.22.02462
Availability: https://pure.qub.ac.uk/en/publications/27e83e85-c2f2-4bab-a401-36fec578ee00
https://doi.org/10.1200/jco.22.02462
https://pureadmin.qub.ac.uk/ws/files/548274535/MMREndorsementDRAFT2022_09_14_1_.pdf
https://www.scopus.com/pages/publications/85149831285
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.C78F37EC
Database: BASE
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://pure.qub.ac.uk/en/publications/27e83e85-c2f2-4bab-a401-36fec578ee00#
    Name: EDS - BASE (ns324271)
    Category: fullText
    Text: View record from BASE
Header DbId: edsbas
DbLabel: BASE
An: edsbas.C78F37EC
RelevancyScore: 929
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 929.480346679688
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mismatch repair and microsatellite instability testing for Immune Checkpoint Inhibitor Therapy: ASCO endorsement of College of American Pathologists Guideline
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Vikas%2C+Praveen%22">Vikas, Praveen</searchLink><br /><searchLink fieldCode="AR" term="%22Messersmith%2C+Hans%22">Messersmith, Hans</searchLink><br /><searchLink fieldCode="AR" term="%22Compton%2C+Carolyn%22">Compton, Carolyn</searchLink><br /><searchLink fieldCode="AR" term="%22Sholl%2C+Lynette%22">Sholl, Lynette</searchLink><br /><searchLink fieldCode="AR" term="%22Broaddus%2C+Russell+R%2E%22">Broaddus, Russell R.</searchLink><br /><searchLink fieldCode="AR" term="%22Davis%2C+Anjee%22">Davis, Anjee</searchLink><br /><searchLink fieldCode="AR" term="%22Estevez-Diz%2C+Maria%22">Estevez-Diz, Maria</searchLink><br /><searchLink fieldCode="AR" term="%22Garje%2C+Rohan%22">Garje, Rohan</searchLink><br /><searchLink fieldCode="AR" term="%22Konstantinopoulos%2C+Panagiotis+A%2E%22">Konstantinopoulos, Panagiotis A.</searchLink><br /><searchLink fieldCode="AR" term="%22Leiser%2C+Aliza%22">Leiser, Aliza</searchLink><br /><searchLink fieldCode="AR" term="%22Mills%2C+Anne+M%2E%22">Mills, Anne M.</searchLink><br /><searchLink fieldCode="AR" term="%22Norquist%2C+Barbara%22">Norquist, Barbara</searchLink><br /><searchLink fieldCode="AR" term="%22Overman%2C+Michael+J%2E%22">Overman, Michael J.</searchLink><br /><searchLink fieldCode="AR" term="%22Sohal%2C+Davendra%22">Sohal, Davendra</searchLink><br /><searchLink fieldCode="AR" term="%22Turkington%2C+Richard+C%2E%22">Turkington, Richard C.</searchLink><br /><searchLink fieldCode="AR" term="%22Johnson%2C+Tyler%22">Johnson, Tyler</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Vikas, P, Messersmith, H, Compton, C, Sholl, L, Broaddus, R R, Davis, A, Estevez-Diz, M, Garje, R, Konstantinopoulos, P A, Leiser, A, Mills, A M, Norquist, B, Overman, M J, Sohal, D, Turkington, R C & Johnson, T 2023, 'Mismatch repair and microsatellite instability testing for Immune Checkpoint Inhibitor Therapy: ASCO endorsement of College of American Pathologists Guideline', Journal of Clinical Oncology, vol. 41, no. 10, pp. 1943-1948. https://doi.org/10.1200/jco.22.02462
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2023
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: Queen's University Belfast: Research Portal
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Cancer+Research%22">Cancer Research</searchLink><br /><searchLink fieldCode="DE" term="%22Oncology%22">Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22%2Fdk%2Fatira%2Fpure%2Fsustainabledevelopmentgoals%2Fgood%5Fhealth%5Fand%5Fwell%5Fbeing%22">/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being</searchLink><br /><searchLink fieldCode="DE" term="%22name=SDG+3+-+Good+Health+and+Well-being%22">name=SDG 3 - Good Health and Well-being</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: The College of American Pathologists (CAP) has developed a guideline on testing for mismatch repair (MMR) and microsatellite instability (MSI) for patients considered for immune checkpoint inhibitor therapy. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. The CAP guideline was reviewed for developmental rigor by methodologists. An ASCO Endorsement Panel subsequently reviewed the content and the recommendations. The ASCO Endorsement Panel determined that the recommendations from the CAP guideline, published on August 3, 2022, are clear, thorough, and based on the most relevant scientific evidence. ASCO endorses . Within the guideline, MMR immunohistochemistry (IHC), MSI polymerase chain reaction, and MSI next-generation sequencing are all recommended testing options for colorectal cancer, MMR-IHC and MSI-polymerase chain reaction for gastroesophageal and small bowel cancer, and only MMR-IHC for endometrial cancer. No recommendation in favor of any testing method over another could be made for any other cancer. Tumor mutational burden was not recommended as a surrogate for DNA MMR deficiency. If MMR deficiency consistent with Lynch syndrome is detected, it should be communicated to the treating physician.Additional information is available at www.asco.org/molecular-testing-and-biomarkers-guidelines.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article in journal/newspaper
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: application/pdf
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 0732-183X<br />1527-7755
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: info:eu-repo/semantics/altIdentifier/pissn/0732-183X; info:eu-repo/semantics/altIdentifier/eissn/1527-7755
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1200/jco.22.02462
– Name: URL
  Label: Availability
  Group: URL
  Data: https://pure.qub.ac.uk/en/publications/27e83e85-c2f2-4bab-a401-36fec578ee00<br />https://doi.org/10.1200/jco.22.02462<br />https://pureadmin.qub.ac.uk/ws/files/548274535/MMREndorsementDRAFT2022_09_14_1_.pdf<br />https://www.scopus.com/pages/publications/85149831285
– Name: Copyright
  Label: Rights
  Group: Cpyrght
  Data: info:eu-repo/semantics/openAccess
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsbas.C78F37EC
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.C78F37EC
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/jco.22.02462
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Cancer Research
        Type: general
      – SubjectFull: Oncology
        Type: general
      – SubjectFull: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
        Type: general
      – SubjectFull: name=SDG 3 - Good Health and Well-being
        Type: general
    Titles:
      – TitleFull: Mismatch repair and microsatellite instability testing for Immune Checkpoint Inhibitor Therapy: ASCO endorsement of College of American Pathologists Guideline
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vikas, Praveen
      – PersonEntity:
          Name:
            NameFull: Messersmith, Hans
      – PersonEntity:
          Name:
            NameFull: Compton, Carolyn
      – PersonEntity:
          Name:
            NameFull: Sholl, Lynette
      – PersonEntity:
          Name:
            NameFull: Broaddus, Russell R.
      – PersonEntity:
          Name:
            NameFull: Davis, Anjee
      – PersonEntity:
          Name:
            NameFull: Estevez-Diz, Maria
      – PersonEntity:
          Name:
            NameFull: Garje, Rohan
      – PersonEntity:
          Name:
            NameFull: Konstantinopoulos, Panagiotis A.
      – PersonEntity:
          Name:
            NameFull: Leiser, Aliza
      – PersonEntity:
          Name:
            NameFull: Mills, Anne M.
      – PersonEntity:
          Name:
            NameFull: Norquist, Barbara
      – PersonEntity:
          Name:
            NameFull: Overman, Michael J.
      – PersonEntity:
          Name:
            NameFull: Sohal, Davendra
      – PersonEntity:
          Name:
            NameFull: Turkington, Richard C.
      – PersonEntity:
          Name:
            NameFull: Johnson, Tyler
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 0732183X
            – Type: issn-print
              Value: 15277755
            – Type: issn-locals
              Value: edsbas
            – Type: issn-locals
              Value: edsbas.oa
          Titles:
            – TitleFull: Vikas, P, Messersmith, H, Compton, C, Sholl, L, Broaddus, R R, Davis, A, Estevez-Diz, M, Garje, R, Konstantinopoulos, P A, Leiser, A, Mills, A M, Norquist, B, Overman, M J, Sohal, D, Turkington, R C & Johnson, T 2023, 'Mismatch repair and microsatellite instability testing for Immune Checkpoint Inhibitor Therapy: ASCO endorsement of College of American Pathologists Guideline', Journal of Clinical Oncology, vol. 41, no. 10, pp. 1943-1948. https://doi.org/10.1200/jco.22.02462
              Type: main
ResultId 1